Erlotinib hydrochloride

For Research Use Only.
Category
Impurities
Cat.No.
NP3672
CAS
183319-69-9
Product Name
Erlotinib hydrochloride
Structure
Structure

Product Details

Description
Erlotinib HCl potently inhibits EGFR activation in intact cells including HNS human head and neck tumor cells (IC50 = 20 nM), DiFi humancolon cancer cells and MDA MB-468 human breast cancer cells.
Synonyms
OSI-744; OSI744; OSI 744; Tarceva; 4-(m-Ethynylanilino)-6,7-bis(2-methoxyethoxy)quinazoline monohydrochloride; 6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride
IUPAC Name
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride
Molecular Weight
429.90
Molecular Formula
C22H23N3O4.HCl
Canonical SMILES
COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl
InChI
InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H
InChIKey
GTTBEUCJPZQMDZ-UHFFFAOYSA-N
Boiling Point
553.6°C at 760 mmHg
Melting Point
223-225°C
Purity
>98%
Solubility
Soluble in Acetic Acid, Dimethylformamide, Dimethyl Sulfoxide, Methanol
Appearance
Off-white Solid
Application
Antineoplastic Agents
Storage
Store at 2-8°C
Packaging
25 g

QC Data

Online Inquiry
×
Top
Inquiry Basket